California State Teachers Retirement System Fate Therapeutics Inc Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

A detailed history of California State Teachers Retirement System transactions in Fate Therapeutics Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 81,778 shares of FATE stock, worth $120,213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81,778
Previous 89,653 8.78%
Holding current value
$120,213
Previous $294,000 2.72%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.12 - $5.57 $24,570 - $43,863
-7,875 Reduced 8.78%
81,778 $286,000
Q2 2024

Aug 14, 2024
BUY
$3.26 - $7.08 $264,493 - $574,421
81,133 Added 952.27%
89,653 $294,000
Q1 2024

May 15, 2024
SELL
$3.54 - $8.35 $19,222 - $45,340
-5,430 Reduced 38.92%
8,520 $62,000
Q4 2023

Feb 13, 2024
SELL
$1.65 - $3.94 $122,547 - $292,627
-74,271 Reduced 84.19%
13,950 $52,000
Q3 2023

Nov 14, 2023
SELL
$2.02 - $5.04 $18,274 - $45,596
-9,047 Reduced 9.3%
88,221 $187,000
Q2 2023

Aug 21, 2023
SELL
$4.76 - $6.59 $9,172 - $12,698
-1,927 Reduced 1.94%
97,268 $462,000
Q1 2023

May 09, 2023
SELL
$4.24 - $11.12 $5,910 - $15,501
-1,394 Reduced 1.39%
99,195 $565,000
Q4 2022

Feb 14, 2023
BUY
$9.86 - $23.83 $12,305 - $29,739
1,248 Added 1.26%
100,589 $1.01 Million
Q3 2022

Nov 18, 2022
SELL
$21.04 - $36.06 $39,281 - $67,324
-1,867 Reduced 1.84%
99,341 $2.23 Million
Q2 2022

Aug 15, 2022
BUY
$17.78 - $42.39 $25,229 - $60,151
1,419 Added 1.42%
101,208 $2.51 Million
Q1 2022

May 16, 2022
SELL
$29.67 - $60.28 $261,096 - $530,464
-8,800 Reduced 8.1%
99,789 $3.87 Million
Q4 2021

Feb 15, 2022
BUY
$47.84 - $64.34 $148,016 - $199,067
3,094 Added 2.93%
108,589 $6.35 Million
Q3 2021

Nov 15, 2021
SELL
$59.27 - $95.73 $296,824 - $479,415
-5,008 Reduced 4.53%
105,495 $6.25 Million
Q2 2021

Aug 16, 2021
SELL
$67.25 - $92.52 $293,210 - $403,387
-4,360 Reduced 3.8%
110,503 $9.59 Million
Q1 2021

May 18, 2021
BUY
$72.16 - $117.4 $470,483 - $765,448
6,520 Added 6.02%
114,863 $9.47 Million
Q4 2020

Feb 16, 2021
SELL
$38.09 - $100.95 $2,437 - $6,460
-64 Reduced 0.06%
108,343 $9.85 Million
Q3 2020

Nov 17, 2020
BUY
$30.41 - $40.5 $424,736 - $565,663
13,967 Added 14.79%
108,407 $4.33 Million
Q2 2020

Aug 17, 2020
BUY
$20.21 - $35.23 $45,189 - $78,774
2,236 Added 2.43%
94,440 $3.24 Million
Q1 2020

May 13, 2020
SELL
$17.28 - $31.88 $7,896 - $14,569
-457 Reduced 0.49%
92,204 $2.05 Million
Q4 2019

Feb 14, 2020
BUY
$13.39 - $20.73 $149,204 - $230,994
11,143 Added 13.67%
92,661 $1.81 Million
Q3 2019

Nov 15, 2019
BUY
$15.47 - $22.5 $15,067 - $21,915
974 Added 1.21%
81,518 $1.27 Million
Q2 2019

Aug 14, 2019
SELL
$15.61 - $20.44 $203,008 - $265,822
-13,005 Reduced 13.9%
80,544 $1.64 Million
Q1 2019

May 09, 2019
SELL
$13.15 - $18.71 $18,225 - $25,932
-1,386 Reduced 1.46%
93,549 $1.64 Million
Q4 2018

Feb 13, 2019
BUY
$11.48 - $16.98 $207,833 - $307,405
18,104 Added 23.56%
94,935 $1.22 Million
Q3 2018

Nov 14, 2018
BUY
$8.75 - $16.29 $6,825 - $12,706
780 Added 1.03%
76,831 $1.25 Million
Q2 2018

Aug 14, 2018
BUY
$9.16 - $13.48 $23,074 - $33,956
2,519 Added 3.43%
76,051 $862,000
Q1 2018

May 15, 2018
BUY
$6.3 - $13.77 $82,101 - $179,450
13,032 Added 21.54%
73,532 $718,000
Q4 2017

Feb 14, 2018
SELL
$3.94 - $6.64 $8,668 - $14,608
-2,200 Reduced 3.51%
60,500 $370,000
Q3 2017

Nov 13, 2017
BUY
$2.6 - $4.31 $163,020 - $270,237
62,700
62,700 $248,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $143M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email